7
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Systemic Sclerosis 'State of the Art'1995

Pages 194-196 | Received 22 May 1995, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

G Sandqvist, M Eklund, A Åkesson & U Nordenskiöld. (2004) Daily activities and hand function in women with scleroderma. Scandinavian Journal of Rheumatology 33:2, pages 102-107.
Read now
CC Mok, TH Kwan & L Chow. (2003) Scleroderma renal crisis sine scleroderma during pregnancy. Scandinavian Journal of Rheumatology 32:1, pages 55-57.
Read now

Articles from other publishers (11)

Manal FardounSuzanne A. NasserAhmed F. El-Yazbi & Ali H. Eid. (2023) GPER Acts Through the cAMP/Epac/JNK/AP-1 Pathway to Induce Transcription of Alpha 2C Adrenoceptor in Human Microvascular Smooth Muscle Cells. Journal of Cardiovascular Pharmacology 82:6, pages 470-479.
Crossref
Merih AKKAPULU & Ali Erdinç YALIN. (2019) Raynaud Fenomeni üzerine genetik yapı, östrojen ve toksik ajanların klinik etkileriThe clinical effects of genetic structure, estrogen, and toxic agents on Raynaud’s Phenomenon. Mersin Üniversitesi Sağlık Bilimleri Dergisi 12:1, pages 143-149.
Crossref
Manal M. Fardoun, Joseph Nassif, Khodr Issa, Elias Baydoun & Ali H. Eid. (2016) Raynaud’s Phenomenon: A Brief Review of the Underlying Mechanisms. Frontiers in Pharmacology 7.
Crossref
Neslihan Yilmaz, Aynur Mollahasanoglu, Hakan Gurvit, Meryem Can, Nese Tuncer, Nevsun İnanc & Sule Yavuz. (2012) Dysexecutive Syndrome. Cognitive and Behavioral Neurology 25:2, pages 57-62.
Crossref
G. Milio, E. Corrado, C. Genova, C. Amato, F. Raimondi, P. L. Almasio & S. Novo. (2006) Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol. Rheumatology 45:8, pages 999-1004.
Crossref
M. Cutolo, C. Pizzorni, M. Tuccio, A. Burroni, C. Craviotto, M. Basso, B. Seriolo & A. Sulli. (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:6, pages 719-726.
Crossref
Nicholas A Flavahan, Sheila Flavahan, Srabani Mitra & Maqsood A Chotani. (2003) The vasculopathy of Raynaud's phenomenon and scleroderma. Rheumatic Disease Clinics of North America 29:2, pages 275-291.
Crossref
Fabrice Lefèvre, Roselyne Garnotel, Nadine Georges & Philippe Gillery. (2001) Modulation of Collagen Metabolism by the Nucleolar Protein Fibrillarin. Experimental Cell Research 271:1, pages 84-93.
Crossref
M. Cutolo, F. Nobili, A. Sulli, C. Pizzorni, M. Briata, F. Faelli, P. Vitali, G. Mariani, F. Copello, B. Seriolo, C. Barone & G. Rodriguez. (2000) Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology 39:12, pages 1366-1373.
Crossref
Ulla K. Samuelson & E. Monica Ahlmén. (2000) Development and evaluation of a patient education program for persons with systemic sclerosis (scleroderma). Arthritis & Rheumatism 13:3, pages 141-148.
Crossref
Hervé Serpier, Philippe Gillery, Véronique Salmon-Ehr, Roselyne Garnotel, Nadine Georges, Bernard Kalis & François-Xavier Maquart. (1997) Antagonistic Effects of Interferon-γ and Interleukin-4 on Fibroblast Cultures.. Journal of Investigative Dermatology 109:2, pages 158-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.